Open Access Highly Accessed Research article

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

Peter Matthews*, Marc Alpert, Galia Rahav, Denise Rill, Edward Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C McGovern and , for the Tigecycline 900 cSSSI Study Group

BMC Infectious Diseases 2012, 12:297 doi:10.1186/1471-2334-12-297

No comments have yet been made on this article.

Post a comment